Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Solid Tumor × Interleukin-2 × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 3 Melanoma 2 Kidney Neoplasms 2 Solid Tumors 1 Solid Tumor 1 Skin Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

alpha-Synuclein 2 Cyclophosphamide 2 temsirolimus 1 fludarabine 1 Valproic Acid 1 Resistant Starch 1 Paclitaxel 1 Interleukin-2 1 Indocyanine Green 1 Carboxylesterase 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05649618 2022-12-14

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡